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Background: The Catechol-O-Methyl Transferase (COMT) gene polymorphism (I/D of C nucleotide at base position
900) has been previously implicated in the development of type 2 diabetes (T2D) and kidney disease. So, aim of
this study was to find association of I/D polymorphism with T2D, and its associated factors like family history and
nephropathy (End Stage Renal Disease, ESRD) patients in a cohort of Pakistani Punjabis.
Methods: Genomic DNA was extracted from human subjects divided as four study groups: controls (n = 46),
diabetics (n = 46), diabetics with nephropathy/ESRD (n = 53), and non-diabetics without nephropathy/ESRD (n = 43).
The 900 I/D C polymorphism in the COMT gene was tested by PCR-RFLP method. Genotype and allele frequencies
as well as Odds Ratios were calculated for these groups. Groups were compared statistically for the analysis of
genotypes, alleles, biochemical parameters as well as disease status.
Results: In comparison with control group (non-diabetic, non-nephropathy), there was no significant difference in
rest of the three groups for allele or genotype frequencies of COMT gene. However, Chi square (χ2) analysis identified a
significant (p = 0.02) correlation of the 900 I/D C polymorphism with family history of diabetes, as it was found that
greater number (74%) of patients having I allele had a positive family history of T2D.
Conclusions: A significant correlation of the COMT polymorphism (900 I/D C) with the family history of T2D has been
observed, which has not been previously reported in Pakistani Punjabi population, however, this preliminary finding
requires further validation studies.
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Diabetes mellitus (DM) is a metabolic disorder caused
by the chronically high blood glucose levels in the body,
which may be the consequence of defect in insulin
secretion, insulin action or combination of both [1]. The
type 2 diabetes (T2D) which is the predominant form of
diabetes in adults leads to various complications of vital
organs and tissues. One such complication is the Diabetic
Nephropathy (DN), a kidney disease due to hyperglycemia
that affects about 25-40% of the diabetics. According to
the Centers for Disease Control (CDC, USA), kidney* Correspondence: awan.fr@gmail.com
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unless otherwise stated.disease is the ninth leading cause of death [2] and DN is
the main cause of the end stage renal disease (ESRD) [2].
Diabetes brings unique pathological changes in the kidney
structure and the progression of the kidney disease is ac-
celerated if diabetes is accompanied with hypertension [3].
Several pathophysiological pathways have been implicated
in the development and progression of diabetic nephropa-
thy, and one of these is the dopaminergenic pathway.
Dopamine system is an important modulator of the renal
differentiation, and is very important for the regulation of
salt metabolism. Dopamine acts as natriuretic hormone by
the inhibition of the Na+- K+-ATPase and other sodium
transporters in several tubular segments. The Catechol-O-
Methyl Transferase (COMT) is one of the important genes
of the dopaminergenic pathway with a main function of
COMT is to remove toxic metabolites from the body.is is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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codes for two protein variants which differ from each
other on the basis of being soluble and membrane
bounded known as Soluble Catechol-O-Methyl Trans-
ferase (S-COMT) and Membrane-bound Catechol-O-
Methyl Transferase (MB-COMT). Owing to importance
of COMT, it is important to study the function and gen-
etics of COMT in humans to devise targeted therapies
for patients with diabetes and kidney related problems.
A genome – wide linkage scan for genes controlling
urinary albumin excretion revealed the linkage of chromo-
some 22 with diabetic nephropathy [4]. Later research
confirmed that the COMT gene is located on the long (q)
arm of chromosome 22 at position 11.21. One of the in-
sertion/deletion (Ins/Del) single nucleotide polymorphism
of C nucleotide in this gene at base position 900 (i.e. 900
I/D C) has been positively correlated with diabetic kidney
disease [5]. The COMT is located in the proximal tubular
epithelial cells of the kidney where the dopamine synthesis
takes place. According to a study conducted in the
Chinese population, it has been reported that dopa-
minergic pathway plays a potential role in the sodium
retention in peripheral tubules and also in regulating
blood pressure [6]. An association of dopaminergenic
pathway genes with kidney diseases among type 2 dia-
betics was investigated in Asian Indian population, and
the results showed positive correlation of COMT gene
polymorphism (900 I/D C) with chronic renal insuffi-
ciency [5]. Some experimental evidences indicate that
the administration of nitecapone, which is an inhibitor
of dopamine metabolizing enzyme, COMT (EC 2.1.1.6)
has been found to effectively abolish glomerular hyper-
tension, and reduce progression to glomerulosclerosis
by inhibiting Na+-K+-ATPase activity [7,8].
Thus, due to the significant role of the COMT gene
polymorphism in kidney functions and diabetes, in this
study, we investigated the associations of this risk poly-
morphism (900 I/D C) in COMT gene by PCR-RFLP
analysis through case control association study in con-
trol and diabetic patients with or without kidney disease
in Pakistani Punjabi population.
Material and methods
A total of 191 subjects divided in four groups were in-
cluded in this study. The groups were: G1-C (Healthy
Controls no diabetes and no nephropathy, n = 46, age
(mean ± SD years) and percentage of males = 45.6 ± 8.4
(48%), females = 46.2 ± 8.4 (52%)), G2-D (Type 2 dia-
betics but without nephropathy, n = 46, age (mean ±
SD years) and percentage of males = 79.8 ± 10.4 (64%),
females = 54.3 ± 10.4 (36%)), G3-DN (Type 2 Diabetics
with Nephropathy / ESRD, DN: n = 53, age (mean ± SD
years) and percentage of males = 54.2 ± 9.7 (57%),
females = 55 ± 6.7 (43%)), G4-N (Non-diabetics buthaving Nephropathy/ESRD called as Control Nephropathy/
Nephropathy, n = 43, age (mean ± SD years) and percentage
of males = 47.7 ± 11.7 (56%), females =47.8 ± 13.2 (44%)).
Samples from G1-C and G2-D were either collected by
arranging diabetes camps (locally called sugar camps) in
schools, public places or through personal contacts at
Faisalabad District, Pakistan, while samples from G3-DN
and G4-N were collected from the Dialysis Units of Allied
Hospital and District Head Quarters Hospital, Faisalabad,
Pakistan. All subjects were above 35 years of age, the
healthy control group (G1-C) inclusion parameters were:
no history of diabetes in their families, their consent to
participate in the study, no hypertension, no kidney dis-
ease, no cancer, and no severe infectious disease. The
diagnosis of diabetes was made according to American
Diabetes Association criteria. The individuals having sys-
tolic and diastolic blood pressures above 120/80 mmHg
were considered as hypertensive. After explaining the
aims of the study, a written informed consent was ob-
tained from each subject, and the study was approved
by the institutional (National Institute for Biotechnology
and Genetic Engineering, Faisalabad, Pakistan) ethics re-
view committee.
Clinical characteristics of subjects
Various demographic and anthropometric measurements
were taken along with blood samples from the subjects
for DNA extraction and for biochemical analysis. Clinically
important analytes such as hemoglobin (Hb), blood glucose,
urea, creatinine, cholesterol, and triglycerides were mea-
sured on a semi-automated clinical chemistry analyzer
(Microlab 300, Merck) (Results not presented here).
Genotyping
The genotyping for COMT gene I/D polymorphism (900
Ins/Del C) was carried out by PCR coupled with Restriction
Fragment Length Polymorphism (RFLP). Three different
genotypes were observed II, DD and ID for COMT gene
polymorphism (I/D). The already reported primers [5] were
used for carrying out the PCR for amplification of COMT
gene. The primers used for COMT gene polymorphism
(I/D) were F-COMT: 5′GACAACGTGATCTGCCCAGG
while melting temperature (Tm) was 64.5 °C and R-
COMT: 5’GAGGTGTGCTTTGCATTTAG with Tm
58.4 °C. PCR for COMT amplification was performed in
0.2 ml tubes containing 30 μL reaction mixture in total.
The reaction mixture was prepared by adding 2.0 μL
samples DNA dilution, 3 μL 10X PCR buffer (750 mM
Tris-HCL, pH 8.8 at 25°C), 1.8 μL MgCl2, 1.8 μL
dNTPs, 0.6 μL of each forward and reverse primer and
0.3 μL Taq DNA polymerase (Fermentas, EU) and 19.9 μL
water to make up the volume 30 μL. The reaction mixture
was taken through thermocycling condition consisting: 10
minutes of denaturation at 94°C for template denaturation
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steps; one minute at 94°C; one minute at 59°C; and one
minute at 72°C for final extension. Final 10 minutes at
72°C for Taq DNA polymerase to synthesize any
remaining un-extended strands. The PCR product of
COMT gene was 279 bp which has one restriction site
for the 6 cutter BglI restriction enzyme. The restriction
reaction using the fast digest Bgl I (Fermentas) was per-
formed in 1.5 mL eppendorf tubes containing 30 μL total
reaction mixture. The reaction mixture was digested at
37°C for 1 hour and run on 2.5-3% agarose gel.Statistical analysis
All the statistical analysis was performed by using SYSTAT
11 for windows software (version 11, Systat Software Inc.,
Chicago, Illinois, USA) and Graphpad Instat (version 3.50).
Clinical characteristics of the subjects were given as
Mean ± SD. The p-value for calculating the significance
of the difference among the clinical characteristics of
different groups was checked by the one-way ANOVA
(ANalysis Of Variance), while disease outcome was
studied by using logistic regression analysis and results
presented as OR (95% Confidence Interval). All the geno-
types were tested for Hardy-Weinberg equilibrium. Chi
square (χ2) analysis was performed for disease association
in groups.Results
COMT genotypes (II, ID, DD) were, firstly amplified by
PCR by subjecting the genomic DNA of all the subjects
under study and then amplicons were separately sub-
jected to restriction enzyme based RFLP assay. Figure 1
shows the PCR amplicon of 279 bp size of the target re-
gion of COMT gene, which was subjected for the identi-
fication of COMT genotypes (II, ID or DD). Therefore,
these PCR products were further restricted by a restric-
tion enzyme to elucidate the genotypes, and the results
are shown in Figure 1 with II (279 bp), DD (171 bp and
108 bp) and ID (279 bp 171 bp and 108 bp) genotypesFigure 1 PCR-RFLP based genotypes of COMT gene polymorphism (I/D). L
the PCR product without the restriction enzyme, Lanes 2,3,4 and 11 contai
6, 9 and 10 contain the ID genotype on 2.5% agarose gel.in some of the representative samples from the studied
subjects.
Baseline characteristics of all four groups were tested
for the association with COMT gene polymorphism.
There were no significant differences among the four
groups for all of the parameters as Body Mass Index
(BMI), blood pressure, hemoglobin, blood glucose, urea,
creatinine, cholesterol, and triglycerides. All the results
were not significant with reference to the genotypes
(results not presented here).
The genotype and allele frequencies for COMT gene
polymorphism were in accordance with Hardy-Weinberg
equilibrium. The allele frequency for I was 0.40 and 0.60
for D allele. The genotype frequency for II was 29 (15.4%),
for ID was 96 (50.3%) and for DD was 66 (34.3%) in the
study subjects. The Table 1 shows allele and genotype fre-
quencies of COMT polymorphism (I/D) for each group in-
dividually. This table (Table 1) also shows the genotype
and allelic distribution of I/D polymorphism for COMT
gene between the cases and controls. There was no signifi-
cant difference between the genotype and allele frequency
among the three groups (G2-D, G3-DN and G4-N) versus
controls (G1-C).
The Chi square analysis for the association of COMT
polymorphism (I/D) with family history of diabetes,
nephropathy and hypertension was also performed
(Table 2). An important though preliminary novel find-
ing from this analysis was a significant correlation of
the COMT gene polymorphism with the family history
of disease. No such correlation has been previously re-
ported for this gene at least in Pakistani population.
From the Chi-square analysis (Table 2) for COMT
polymorphism, it is evident that the high percentage
(74%) of subjects with family history of diabetes had II
genotype. The percentage of the people with the ID
and DD genotype having hypertension was also higher
but the p-value showed that the result was not signifi-
cant (p = 0.93). From the Chi-square analysis for ne-
phropathy the results were also not significant as the
p-value was more than 0.05.anes M on both ends contain the 100 bp DNA ladder, Lane 1 contains
ns the II genotype, Lane 5, 7, and 8 contains DD genotype and Lanes
Table 1 Allele and genotype frequency of COMT polymorphism (I/D) of study cohorts
G1-C G2-D G3-DN G4-CN
Genotypes
Genotyped numbers* 46 46 56 43
n (%)
II 7 (15.2) 8 (17.3) 8 (14.2) 4 (9.3)
ID 23 (50.0) 23 (50.0) 31 (55.3) 20 (46.5)
DD 16 (34.7) 15 (32.6) 17 (30.3) 19(44.1)
p value** - 0.95 0.85 0.55
Allele Frequency I 37 (40.2) 39 (42.3) 28 (32.5) 28 (32.5)
D 55 (59.7) 53 (57.6) 58 (67.4) 58 (67.4)
p value** - 0.76 0.80 0.81
OR (95% CI) - 1.09 (0.60-1.96) 1.07 (0.61-1.88) 0.56 (0.29-1.07)
*G: Group, C: Control, D: Type 2 Diabetics: DN: Diabetic Nephropathy, CN: Non-diabetic nephropathy, OR: Odds Ratio, 95% CI: 95% Confidence Interval. **The
comparisons of the p value are among Control group (G1-C) with other three groups (G2-D, G3-DN, G4-CN) for genotype and allele distributions. The Odds Ratio
is calculated by logistic regression analysis.
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The catechol-o-methyl transferase (COMT) gene is an
important member of the dopaminergenic pathway. This
pathway has been investigated in some studies for its
association with diabetes and kidney disease. Hence, the
present report describes a case-control association study
of insertion/deletion polymorphism of C nucleotide at
base position 900 in the COMT gene (i.e. 900 I/D C) for
its association with diabetes and nephropathy along with
related parameters e.g. hypertension and family history
of disease.
The COMT was chosen for the present investigation
as it has been previously reported to be involved in the
regulation of blood pressure through catecholamine me-
tabolism. Moreover, dopamine owing to its potential role
as natriuretic hormone is implicated to play a role in the
development and function of the kidney. Such role of
dopamine has been supported from the functional stud-
ies using the COMT inhibitor in the diabetic kidney
disease in rats [7,8]. Genetic association studies of the
dopamine receptor genes and COMT were linked to
essential hypertension [9].
Furthermore, dopamine also regulates the activity of
Angiotensin II which is the key component of ReninTable 2 Effect of COMT gene polymorphism (I/D) on family hi
Status II
Family history of diabetes Yes 20 (74.0%)
No 7 (25.9%)
**Hypertension Yes 10 (37.0%)
No 17 (62.9%)
***Nephropathy Yes 12 (44.4%)
No 15 (55.6%)
*p value is considered as significant when p <0.05. **Hypertension: when systolic a
when patients have end stage renal disease and were on dialysis. Comparison for yAngiotensin Aldosterone System (RAAS) pathway. So, an
interplay of dopamine and Angiotensin II could disturb the
vascular tone, sodium ion balance and renal injury [10]. Ex-
periments in rats have shown that COMT inhibition could
reverse renal abnormalities, and thus can provide protec-
tion from the development of diabetic nephropathy [8].
Association of COMT gene with diabetes and nephropa-
thy has been reported in a study conducted in the Asian
Indian population in which a genetic variant showed asso-
ciation for diabetic nephropathy [5]. Owing to its import-
ance in metabolic disorders, the COMT was selected as
candidate gene for polymorphism of genotypes in a small
group of Pakistani Punjabi population from Faisalabad re-
gion. As the population of this region was shared between
the two countries (India and Pakistan) prior to inde-
pendence and both regions have similar environmental
conditions. Additionally, the association of common
biochemical and clinical parameters was assessed for
this COMT polymorphism with diabetes and nephrop-
athy in Pakistani Punjabi population.
Conclusions
The main finding of this study was a positive correlation
of family history of diabetes with COMT (900 I/D C)story of diabetes, hypertension and nephropathy
ID DD *p value
45(48.3%) 41 (64.1%) 0.02
48(51.6%) 23 (35.9%)
40 (44.0%) 35 (53.0%) 0.31
51(56.0%) 31 (46.9%)
51 (52.6%) 36 (53.7%) 0.70
46 (47.4%) 31 (46.2%)
nd diastolic blood pressure was more than 120/80 mm Hg. ***Nephropathy:
es/no in the same category of status was calculated by the chi square analysis.
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Since, this is a preliminary finding from a small number
of samples; it is therefore, suggested that a large number
of samples should be analyzed in future to validate this
result. If such an association is established, it will help to
minimize the risk of development of disease in genetic-
ally predisposed individuals by earlier interventions.
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